8-K 1 a04-1555_18k.htm 8-K

 

SECURITIES AND EXCHANGE COMMISSION

 

Washington, D.C. 20549

 

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): January 26, 2004

 

BIOSITE INCORPORATED

(Exact name of registrant as specified in its charter)

 

Delaware

 

000-21873

 

33-0288606

(State or other jurisdiction
of incorporation)

 

(Commission
File Number)

 

(IRS Employer
Identification No.)

 

11030 Roselle Street, San Diego, California 92121

(Address of principal executive offices)     (Zip Code)

 

Registrant’s telephone number, including area code:  (858) 455-4808

 

 

 

ITEM 7                                                        FINANCIAL STATEMENTS AND EXHIBITS.

 

(c)                                                Exhibits.

 

Exhibit 99.1                                    Press release of Biosite Incorporated dated January 26, 2004

ITEM 9                                                        REGULATION FD DISCLOSURE (INFORMATION FURNISHED PURSUANT TO ITEM 12, “DISCLOSURE OF RESULTS OF OPERATIONS AND FINANCIAL CONDITION”).

 

On January 26, 2004, Biosite Incorporated issued an earnings release announcing its financial results for the fourth quarter ended December 31, 2003.  A copy of the earnings release is attached as Exhibit 99.1 to this Form 8-K.

 

The information contained in this Item 9 of this Current Report is being furnished pursuant to “Item 12. Results of Operations and Financial Condition” of Form 8-K in accordance with SEC Release No. 33-8216.

 

The information in this Current Report and attached Exhibit are being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section.  The information in this Current Report and attached Exhibit shall not be deemed incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.

 

2

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: January 26, 2004

 

 

 

BIOSITE INCORPORATED

 

 

 

 

 

By:

/s/ CHRISTOPHER J. TWOMEY

 

 

 

 

 

Christopher J. Twomey

 

 

Vice President, Finance and

 

 

Chief Financial Officer

 

3

 

INDEX TO EXHIBITS

 

Exhibit
Number

 

Exhibit

 

 

 

Exhibit 99.1

 

Press release of Biosite Incorporated dated January 26, 2004

 

4